You have 9 free searches left this month | for more free features.

Condition

Hematologic Malignancies (1)

Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Zhejiang Genfleet Therapeutics Co., Ltd. (2)

Collaborator

Intervention

gfh009 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

gfh009

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Trial (GFH009)

Not yet recruiting

Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

GFH009

(no location specified)

Jun 28, 2023

Hematologic Malignancies Trial in China, United States (GFH009)

Recruiting

Hematologic Malignancies

GFH009

New Orleans, Louisiana
+16 more

Aug 2, 2022